The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 48 (1), 983-996
- https://doi.org/10.1080/21691401.2020.1773489
Abstract
High grade-gliomas are highly invasive and prone to metastasis, leading to poor survival and prognosis. Currently, we urgently need a new treatment strategy to effectively inhibit glioma. In this study, artemether and paclitaxel were used as two agents for tumour suppression. Two functional materials were synthesised and modified on the surface of the micelle as targeting molecules. The addition of two functional materials confers the ability of the micelles to effectively cross the blood-brain barrier (BBB) and then target the glioma cells. Thus, this dual-targeted delivery system allows the drug to play a better role in inhibiting tumour invasion and vasculogenic mimicry (VM) channels. In this paper, the anticancer effects of dual-targeted artemether plus paclitaxel micelles on glioma U87 cells were studied in three aspects: (I) In vitro and in vivo targeting assessment, including the role of penetrating BBB and targeting glioma; (II) In vitro regulation of invasion-associated proteins; (III) Inhibition of VM channels formation and invasion in vitro; (IV) The study of pharmacodynamics in tumour-bearing mice. These results suggest that dual-targeted artemether plus paclitaxel micelle may provide a new strategy to treat glioma via inhibiting invasive and VM channels.Keywords
Funding Information
- Research Centre for Engineering (Technology) of Traditional Chinese Medicine Microemulsions
- New Biological Preparations, Shanxi University of Chinese Medicine
- Shanxi Province Science Foundation for Youths (201801D221434)
- National Natural Science Foundation of China (81903813)
- Scientific Research Fund of Shanxi Administration of Traditional Chinese Medicine (2016ZYYC23)
- Scientific and Technological Innovation Ability Cultivation Project of Shanxi University of Chinese Medicine (2019PY-140)
- Shanxi Education Science
- special research project
This publication has 41 references indexed in Scilit:
- Primary Neoplasms of the Pediatric BrainRadiologic Clinics of North America, 2019
- Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranosticsChemical Society Reviews, 2019
- Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized TrialCancer Cell, 2018
- Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills GliomaACS Nano, 2018
- Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade gliomaNature, 2017
- Mutations in chromatin machinery and pediatric high-grade gliomaScience Advances, 2016
- Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma TherapyACS Applied Materials & Interfaces, 2015
- Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain gliomaBiomaterials, 2014
- Disruption of astrocyte–vascular coupling and the blood–brain barrier by invading glioma cellsNature Communications, 2014
- Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and scienceExpert Review of Molecular Diagnostics, 2014